SCHEMBL7343200

SCHEMBL7343200

CCC(Cc1ccccc1)NC1Cc2cccc3oc(=O)n(c23)C1

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 13/20 0.36
DRD3 P35462 13/20 0.36
HTR1A P08908 3/20 0.36
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6361234 0.76 DRD2 (0.61) DRD2DRD3HTR1A
SCHEMBL7343202 0.70 HTR1A (0.52) DRD2DRD3HTR1A
SCHEMBL7343414 0.67 HTR1A (0.40) DRD2DRD3HTR1A
SCHEMBL6354089 0.67 HTR1A (0.56) DRD2DRD3HTR1A
SCHEMBL7341577 0.63 CBX7 (0.40) HTR1A
SCHEMBL7340482 0.63 CBX7 (0.41) HTR1A
SCHEMBL9776910 0.61 GRIN2B (0.54) DRD2DRD3SLC6A4
SCHEMBL9125976 0.60 CYP11B1 (0.32) HTR1A
SCHEMBL10507841 0.60 DRD2 (0.57) DRD2DRD3HTR1A
SCHEMBL21243263 0.59 SIGMAR1 (0.53) SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed